Stoke Therapeutics (STOK) Insider Trading & Ownership $11.61 -0.07 (-0.60%) (As of 05:27 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Stoke Therapeutics (NASDAQ:STOK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$70.21 M Get STOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address STOK Insider Buying and Selling by Quarter Ad Insiders ExposedMysterious drone activity triggers massive 1,366% surgeIf mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.👉 Click here now to see how this signal works. Stoke Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/9/2024Barry TichoInsiderSell2,586$12.99$33,592.14 12/9/2024Edward M Md KayeCEOSell6,786$12.99$88,150.14 12/9/2024Jonathan AllanGeneral CounselSell13,666$13.61$185,994.26 12/6/2024Barry TichoInsiderSell13,945$12.78$178,217.10 12/6/2024Edward M Md KayeCEOSell6,170$12.78$78,852.60 12/6/2024Jonathan AllanGeneral CounselSell9,696$12.78$123,914.88 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/2/2024Barry TichoInsiderSell10,000$12.07$120,700.00 9/19/2024Skorpios TrustMajor ShareholderSell1,937,500$14.05$27,221,875.00 7/1/2024Barry TichoInsiderSell10,000$13.75$137,500.00 4/17/2024Skorpios TrustMajor ShareholderSell3,600,000$11.60$41,760,000.00 3/28/2024Jonathan AllanGeneral CounselSell5,126$13.20$67,663.20 3/19/2024Edward M Md KayeCEOSell11,150$6.10$68,015.00 3/19/2024Jonathan AllanGeneral CounselSell2,349$6.10$14,328.90 3/19/2024Stephen J TulipanoCFOSell4,116$6.10$25,107.60 2/1/2024Barry TichoInsiderSell10,000$4.80$48,000.00 1/2/2024Barry TichoInsiderSell10,000$5.74$57,400.00 (Data available from 1/1/2013 forward) STOK Insider Trading Activity - Frequently Asked Questions Who is on Stoke Therapeutics's Insider Roster? The list of insiders at Stoke Therapeutics includes Barry Ticho, Edward M Md Kaye, Huw M Nash, Jonathan Allan, Skorpios Trust, and Stephen J Tulipano. Learn more on insiders at STOK. What percentage of Stoke Therapeutics stock is owned by insiders? 11.30% of Stoke Therapeutics stock is owned by insiders. Learn more on STOK's insider holdings. Which Stoke Therapeutics insiders have been selling company stock? The following insiders have sold STOK shares in the last 24 months: Barry Ticho ($1,498,661.52), Edward M Md Kaye ($235,017.74), Jonathan Allan ($418,160.28), Skorpios Trust ($68,981,875.00), and Stephen J Tulipano ($25,107.60). How much insider selling is happening at Stoke Therapeutics? Insiders have sold a total of 5,744,404 Stoke Therapeutics shares in the last 24 months for a total of $71,158,822.14 sold. Stoke Therapeutics Key ExecutivesDr. Edward M. Kaye M.D. (Age 75)Ph.D., CEO & Director Compensation: $948.9kDr. Adrian R. Krainer Ph.D. (Age 65)Co-Founder & Independent Director Compensation: $44kDr. Barry S. Ticho FACC (Age 63)M.D., Ph.D., Chief Medical Officer Compensation: $684.55kMs. Isabel Aznarez Ph.D. (Age 51)Co-Founder & Group VP of Discovery Research Mr. Thomas Edward Leggett (Age 47)Chief Financial Officer Dr. Huw M. Nash Ph.D. (Age 57)COO & Chief Business Officer Compensation: $429.67kMr. Eric RojasHead of Investor RelationsMr. Jonathan Allan J.D. (Age 34)Corporate Secretary & General Counsel 2 recent tradesMs. Dawn Kalmar (Age 46)Chief Communications Officer Ms. Joan WoodChief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies CPRX Insider Trades AGIO Insider Trades PTGX Insider Trades IOVA Insider Trades AMRX Insider Trades LBPH Insider Trades NAMS Insider Trades IDYA Insider Trades CNTA Insider Trades RXRX Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:STOK) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
